SCHEMBL14540796

SCHEMBL14540796

COc1ccc(C(=O)N2N=C(c3ccccc3)CC2c2cccc3ccccc23)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.68
▸ ERBB2 P04626 3/20 0.68
▸ ERBB3 P21860 2/20 0.68
▸ KDR P35968 2/20 0.68
▸ PTK2 Q05397 2/20 0.68
▸ PKM P14618 1/20 0.64
▸ APC P25054 2/20 0.64
▸ CA1 P00915 3/20 0.61
▸ CA2 P00918 3/20 0.61
▸ KMT2A Q03164 3/20 0.61
▸ MEN1 O00255 2/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.59
▸ CA12 O43570 1/20 0.59
▸ CA9 Q16790 1/20 0.59
▸ TERT O14746 1/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ HPGD P15428 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ MAPT P10636 1/20 0.56
▸ MMP2 P08253 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14540795 0.89 NPSR1 (0.73) EGFRERBB2ERBB3KDRPTK2
SCHEMBL14540788 0.86 EGFR (0.67) EGFRERBB2PKMAPCCA1
SCHEMBL14540886 0.84 MEN1 (0.83) CA1CA2KMT2AMEN1NPSR1
SCHEMBL28409452 0.82 CA12 (0.64) EGFRERBB2ERBB3KDRPTK2
SCHEMBL14540884 0.82 KMT2A (0.87) CA1CA2KMT2AMEN1NPSR1
SCHEMBL14541214 0.79 MEN1 (0.76) CA1CA2KMT2AMEN1NPSR1
SCHEMBL28414052 0.78 CA12 (0.65) EGFRERBB2ERBB3KDRPTK2
SCHEMBL14541074 0.77 KMT2A (0.82) PKMCA1CA2KMT2AMEN1
SCHEMBL14541073 0.75 KMT2A (0.69) PKMCA1CA2KMT2AMEN1
SCHEMBL28020452 0.74 EGFR (0.77) EGFRERBB2ERBB3KDRPTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007038425-A2 ANTI-VIRAL COMPOUINDS REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2007-04-05 — — WO disclosed
Send feedback